0
eFFECTOR Therapeutics, Inc. Banner Image

eFFECTOR Therapeutics, Inc.

  • Ticker EFTR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
eFFECTOR Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Solana Beach, California
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of eFFECTOR’s product candidates is designed to actMore on a single protein that regulates, in a coordinated manner, the expression of multiple functionally related proteins that together drive important biological processes such as immune evasion, stress and inflammatory responses, as well as cell proliferation.
REPORT RATINGS
5.0 / 5.0 (1)

eFFECTOR Therapeutics, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

eFFECTOR Therapeutics, Inc.

Most Recent Annual Report

eFFECTOR Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

eFFECTOR Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!